Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Business & Finance › Zealand Pharma loses a fifth of its value as many users...
Business & Finance

Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial

Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
MarketWatch Monday 08 June 2026, 08:44 UTC By Steve Goldstein 1 min read
Key Points

The drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.

The drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.
Zealand Pharma (ORG) Copenhagen (LOCATION)
Originally published by MarketWatch Read original →

Related Stories

Watson keen to start again, downplays Haslam jab

BEREA, Ohio -- Cleveland Browns quarterback Deshaun Watson said Wednesday it is "very important" to get an opportunity to start again after a pair of Achilles surgeries that have sidelined him since October 2024. Watson spoke to local reporters after Cleveland's second day of mandatory minicamp, marking his first comments since he ruptured his right Achilles tendon on Oct. 20, 2024. "I think each and every person that walks into the locker room should have that mindset that you want to start...

ESPN 2m ago

The furious dispute over what caused Air India flight 171 to crash

The final conclusions of the investigation have yet to be published, although more could become apparent in the coming days.

BBC Business 8m ago

'A little goes a long way': New York's candy stores sweeten economic gloom

While US consumer confidence is at an historic low the Big Apple's sweet shops are expanding.

BBC Business 16m ago

I'd have vetoed foreign sale of UK tech giant, says Business Secretary

Peter Kyle's comments come as the government sets out how it would back British technology companies.

BBC Business 16m ago